A novel, soluble compound, C25, sensitizes to TRAIL-induced apoptosis through upregulation of DR5 expression.

Autor: James, Michael A., Seibel, William L., Kupert, Elena, Xiao X. Hu, Potharla, Vishwakanth Y., Anderson, Marshall W.
Zdroj: Anti-Cancer Drugs; Jun2015, Vol. 26 Issue 5, p518-530, 13p
Databáze: Complementary Index